These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24961186)

  • 1. Code stroke: a mismatch between number of activation and number of thrombolysis.
    Sung SF; Tseng MC
    J Formos Med Assoc; 2014 Jul; 113(7):442-6. PubMed ID: 24961186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor.
    Huang P; Chen CH; Yang YH; Lin RT; Lin FC; Liu CK
    Cerebrovasc Dis; 2006; 22(5-6):423-8. PubMed ID: 16912476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke.
    Sun MC; Hsiao PJ
    J Formos Med Assoc; 2015 Oct; 114(10):910-5. PubMed ID: 26239194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of a computerised five-level emergency triage system for patients with acute ischaemic stroke.
    Sung SF; Huang YC; Ong CT; Chen W
    Emerg Med J; 2013 Jun; 30(6):454-8. PubMed ID: 22736717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Alteplase for Acute Ischemic Stroke in Taiwan: Can We Expand the National Health Insurance's Reimbursement Criteria?
    Hsieh CY
    Acta Neurol Taiwan; 2017 Mar; 26(1):1-2. PubMed ID: 28752507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated.
    Kobayashi A; Skowronska M; Litwin T; Czlonkowska A
    Emerg Med J; 2007 Feb; 24(2):96-9. PubMed ID: 17251612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center.
    Hemmen TM; Meyer BC; McClean TL; Lyden PD
    J Stroke Cerebrovasc Dis; 2008; 17(1):23-5. PubMed ID: 18190817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME; Nunziato EC; Labovitz DL
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):808-11. PubMed ID: 21640608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of time to treatment on outcome in very elderly thrombolysed stroke patients.
    Frank B; Fulton RL; Lees KR;
    Int J Stroke; 2014 Jul; 9(5):591-6. PubMed ID: 24588833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild stroke and advanced age are the major reasons for exclusion from thrombolysis in stroke patients admitted within 4.5 hours.
    Liu Y; Zhao H; Zhou J; Wang Q; Chen Z; Luo N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1571-6. PubMed ID: 24582787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pennsylvania comprehensive stroke center collaborative: Statement on the recently updated IV rt-PA prescriber information for acute ischemic stroke.
    Daou B; Deprince M; D'Ambrosio R; Tjoumakaris S; Rosenwasser RH; Ackerman DJ; Bell R; Tzeng DL; Ghobrial M; Fernandez A; Shah Q; Gzesh DJ; Murphy D; Castaldo JE; Mathiesen C; Pineda MC; Jabbour P
    Clin Neurol Neurosurg; 2015 Dec; 139():264-8. PubMed ID: 26539671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

  • 19. National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010.
    Hsieh CY; Chen CH; Chen YC; Kao Yang YH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e620-7. PubMed ID: 24126287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.